Skip Header

Contribute Send feedback
Read comments (?) or add your own

Q8VDQ1 (PTGR2_MOUSE) Reviewed, UniProtKB/Swiss-Prot

Last modified January 25, 2012. Version 80. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (3) | Third-party data text xml rdf/xml gff fasta
to top of pageNames·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order

Names and origin

Protein namesRecommended name:
Prostaglandin reductase 2

Short name=PRG-2
EC=1.3.1.48
Alternative name(s):
15-oxoprostaglandin 13-reductase
Zinc-binding alcohol dehydrogenase domain-containing protein 1
Gene names
Name:Ptgr2
Synonyms:Zadh1
OrganismMus musculus (Mouse)
Taxonomic identifier10090 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresGliresRodentiaSciurognathiMuroideaMuridaeMurinaeMusMus

Protein attributes

Sequence length351 AA.
Sequence statusComplete.
Protein existenceEvidence at protein level

General annotation (Comments)

Function

Functions as 15-oxo-prostaglandin 13-reductase and acts on 15-keto-PGE1, 15-keto-PGE2, 15-keto-PGE1-alpha and 15-keto-PGE2-alpha with highest activity towards 15-keto-PGE2. Overexpression represses transcriptional activity of PPARG and inhibits adipocyte differentiation. Ref.3

Catalytic activity

11-alpha-hydroxy-9,15-dioxoprost-5-enoate + NAD(P)+ = (5Z)-(13E)-11-alpha-hydroxy-9,15-dioxoprosta-5,13-dienoate + NAD(P)H. Ref.3

Subunit structure

Monomer. Ref.4

Subcellular location

Cytoplasm By similarity.

Tissue specificity

Widely expressed with highest levels in adipose tissues. Ref.3

Developmental stage

Highly expressed in the late phase of adipocyte differentiation (at protein level). Ref.3

Sequence similarities

Belongs to the NADP-dependent oxidoreductase L4BD family.

Biophysicochemical properties

Kinetic parameters:

KM=49.6 µM for 15-keto-PGE2 Ref.3

KM=34.4 µM for 15-keto-PGE1

KM=108.8 µM for 15-keto-PGF2-alpha

KM=59.2 µM for 15-keto-PGF2-beta

KM=94.6 µM for NADPH

Vmax=178.4 µmol/min/mg enzyme for 15-keto-PGE2

Vmax=115.0 µmol/min/mg enzyme for 15-keto-PGE1

Vmax=230.9 µmol/min/mg enzyme for 15-keto-PGF2-alpha

Vmax=206.4 µmol/min/mg enzyme for 15-keto-PGF2-beta

Vmax=144.7 µmol/min/mg enzyme for NADPH

Ontologies

Keywords
   Cellular componentCytoplasm
   Coding sequence diversityAlternative splicing
   LigandNADP
   Molecular functionOxidoreductase
   Technical term3D-structure
Complete proteome
Reference proteome
Gene Ontology (GO)
   Biological processprostaglandin metabolic process

Inferred from sequence or structural similarity. Source: UniProtKB

   Cellular componentmitochondrion

Inferred from direct assay. Source: MGI

   Molecular function15-oxoprostaglandin 13-oxidase activity

Inferred from sequence or structural similarity. Source: UniProtKB

nucleotide binding

Inferred from electronic annotation. Source: InterPro

zinc ion binding

Inferred from electronic annotation. Source: InterPro

Complete GO annotation...

Alternative products

This entry describes 2 isoforms produced by alternative splicing. [Align] [Select]
Isoform 1 (identifier: Q8VDQ1-1)

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
Isoform 2 (identifier: Q8VDQ1-2)

The sequence of this isoform differs from the canonical sequence as follows:
     314-316: VKE → FLF
     317-351: Missing.
Note: No experimental confirmation available.

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Chain1 – 351351Prostaglandin reductase 2
PRO_0000218071

Regions

Nucleotide binding165 – 1684NADP
Nucleotide binding253 – 2597NADP
Nucleotide binding287 – 2893NADP
Region99 – 1002Substrate binding By similarity
Region288 – 2903Substrate binding By similarity

Sites

Binding site1921NADP
Binding site2081NADP
Binding site2311NADP
Binding site3371NADP

Natural variations

Alternative sequence314 – 3163VKE → FLF in isoform 2.
VSP_013528
Alternative sequence317 – 35135Missing in isoform 2.
VSP_013529

Experimental info

Mutagenesis2591Y → F: Significant reduction in catalytic efficiency. Ref.3
Sequence conflict181P → T in BAB32284. Ref.1
Sequence conflict311P → L in AAH21466. Ref.2
Sequence conflict811V → I in BAE26315. Ref.1
Sequence conflict811V → I in AAH21466. Ref.2
Sequence conflict911T → A in BAE26315. Ref.1
Sequence conflict911T → A in AAH21466. Ref.2
Sequence conflict2391A → T in BAE26315. Ref.1
Sequence conflict2391A → T in AAH21466. Ref.2
Sequence conflict260 – 2612SN → NK in BAE26315. Ref.1
Sequence conflict260 – 2612SN → NK in AAH21466. Ref.2
Sequence conflict3181M → V in BAE26315. Ref.1
Sequence conflict3181M → V in AAH21466. Ref.2

Secondary structure

.......................................................... 351
Helix Strand Turn

Details...

Sequences

Sequence LengthMass (Da)Tools
Isoform 1 [UniParc].

Last modified July 22, 2008. Version 2.
Checksum: 2766871577A8022F

FASTA35138,015
        10         20         30         40         50         60 
MIIQRVVLNS RPGKNGNPVA ENFRVEEFSL PDALNEGQVQ VRTLYLSVDP YMRCKMNEDT 

        70         80         90        100        110        120 
GTDYLAPWQL AQVADGGGIG VVEESKHQKL TKGDFVTSFY WPWQTKAILD GNGLEKVDPQ 

       130        140        150        160        170        180 
LVDGHLSYFL GAIGMPGLTS LIGVQEKGHI SAGSNQTMVV SGAAGACGSL AGQIGHLLGC 

       190        200        210        220        230        240 
SRVVGICGTQ EKCLFLTSEL GFDAAVNYKT GNVAEQLREA CPGGVDVYFD NVGGDISNAV 

       250        260        270        280        290        300 
ISQMNENSHI ILCGQISQYS NDVPYPPPLP PAVEAIRKER NITRERFTVL NYKDKFEPGI 

       310        320        330        340        350 
LQLSQWFKEG KLKVKETMAK GLENMGVAFQ SMMTGGNVGK QIVCISEDSS L 

« Hide

Isoform 2 [UniParc].

Checksum: 7699BA248C3E09D0
Show »

FASTA31634,449

References

« Hide 'large scale' references
[1]"The transcriptional landscape of the mammalian genome."
Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J. expand/collapse author list , Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.
Science 309:1559-1563(2005) [PubMed: 16141072] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
Strain: C57BL/6J.
Tissue: Cerebellum, Embryonic heart, Mammary gland and Medulla oblongata.
[2]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
Strain: Czech II.
Tissue: Mammary tumor.
[3]"Identification of a novel prostaglandin reductase reveals the involvement of prostaglandin E2 catabolism in regulation of peroxisome proliferator-activated receptor gamma activation."
Chou W.-L., Chuang L.-M., Chou C.-C., Wang A.H.-J., Lawson J.A., FitzGerald G.A., Chang Z.-F.
J. Biol. Chem. 282:18162-18172(2007) [PubMed: 17449869] [Abstract]
Cited for: FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, MUTAGENESIS OF TYR-259.
[4]"Crystal structure of a putative NADPH-dependent oxidoreductase (GI: 18204011) from mouse at 2.10 A resolution."
Levin I., Schwarzenbacher R., McMullan D., Abdubek P., Ambing E., Biorac T., Cambell J., Canaves J.M., Chiu H.-J., Dai X., Deacon A.M., DiDonato M., Elsliger M.-A., Godzik A., Grittini C., Grzechnik S.K., Hampton E., Jaroszewski L. expand/collapse author list , Karlak C., Klock H.E., Koesema E., Kreusch A., Kuhn P., Lesley S.A., McPhillips T.M., Miller M.D., Morse A., Moy K., Ouyang J., Page R., Quijano K., Reyes R., Robb A., Sims E., Spraggon G., Stevens R.C., van den Bedem H., Velasquez J., Vincent J., von Delft F., Wang X., West B., Wolf G., Xu Q., Hodgson K.O., Wooley J., Wilson I.A.
Proteins 56:629-633(2004) [PubMed: 15229897] [Abstract]
Cited for: X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS), SUBUNIT.
[5]"Structural basis for catalytic and inhibitory mechanisms of human prostaglandin reductase PTGR2."
Wu Y.H., Ko T.P., Guo R.T., Hu S.M., Chuang L.M., Wang A.H.
Structure 16:1714-1723(2008) [PubMed: 19000823] [Abstract]
Cited for: X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH NADPH.
+Additional computationally mapped references.

Cross-references

Sequence databases

EMBL
GenBank
DDBJ
AK036168 mRNA. Translation: BAC29329.1.
AK021033 mRNA. Translation: BAB32284.1.
AK145232 mRNA. Translation: BAE26315.1.
AK159932 mRNA. Translation: BAE35493.1.
AK168895 mRNA. Translation: BAE40712.1.
BC021466 mRNA. Translation: AAH21466.1.
IPIIPI00134334.
IPI00556775.
RefSeqNP_001239554.1. NM_001252625.1.
NP_084156.2. NM_029880.3.
UniGeneMm.246127.

3D structure databases

PDBe
RCSB PDB
PDBj
EntryMethodResolution (Å)ChainPositionsPDBsum
1VJ1X-ray2.10A1-351[»]
2ZB3X-ray2.00A1-351[»]
ProteinModelPortalQ8VDQ1.
SMRQ8VDQ1. Positions 2-346.
ModBaseSearch...

PTM databases

PhosphoSiteQ8VDQ1.

Proteomic databases

PRIDEQ8VDQ1.

Protocols and materials databases

StructuralBiologyKnowledgebaseSearch...

Genome annotation databases

EnsemblENSMUST00000110290; ENSMUSP00000105919; ENSMUSG00000072946.
ENSMUST00000123614; ENSMUSP00000115704; ENSMUSG00000072946.
ENSMUST00000146377; ENSMUSP00000119981; ENSMUSG00000072946.
ENSMUST00000147363; ENSMUSP00000114766; ENSMUSG00000072946.
GeneID77219.
KEGGmmu:77219.
UCSCuc007oep.1. mouse.

Organism-specific databases

CTD145482.
MGIMGI:1916372. Ptgr2.

Phylogenomic databases

eggNOGroNOG16229.
GeneTreeENSGT00390000009335.
HOGENOMHBG753318.
HOVERGENHBG055024.
InParanoidQ8VDQ1.
OMAHELCPAG.
OrthoDBEOG4S4PGG.
PhylomeDBQ8VDQ1.

Gene expression databases

ArrayExpressQ8VDQ1.
BgeeQ8VDQ1.
GenevestigatorQ8VDQ1.

Family and domain databases

InterProIPR013149. ADH_C.
IPR002085. ADH_SF_Zn-type.
IPR011032. GroES-like.
IPR016040. NAD(P)-bd_dom.
[Graphical view]
Gene3DG3DSA:3.40.50.720. NAD(P)-bd. 1 hit.
KOK13949.
PANTHERPTHR11695. ADH_Sf_Zn. 1 hit.
PfamPF00107. ADH_zinc_N. 1 hit.
[Graphical view]
SUPFAMSSF50129. GroES_like. 1 hit.
ProtoNetSearch...

Other

NextBio346608.
SOURCESearch...

Entry information

Entry namePTGR2_MOUSE
AccessionPrimary (citable) accession number: Q8VDQ1
Secondary accession number(s): Q3TG36 expand/collapse secondary AC list , Q3ULY3, Q8BZA2, Q9D1W8
Entry history
Integrated into UniProtKB/Swiss-Prot: April 26, 2005
Last sequence update: July 22, 2008
Last modified: January 25, 2012
This is version 80 of the entry and version 2 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation programChordata Protein Annotation Program

Relevant documents

MGD cross-references

Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot

PDB cross-references

Index of Protein Data Bank (PDB) cross-references

SIMILARITY comments

Index of protein domains and families